A
Akido Labs
AI-driven healthcare platform enhancing access to high-quality, personalized care across all specialties
About Akido Labs
Akido Labs is a pioneering healthcare technology company that leverages artificial intelligence to enhance access to high-quality, personalized medical care. Serving a diverse range of clients including primary care providers and specialists, Akido Labs operates in the healthcare technology market. The company's business model revolves around integrating AI with an extensive medical network to provide scalable healthcare solutions. Akido Labs generates revenue through partnerships with healthcare providers, offering them tools to increase patient capacity and improve care outcomes. The company's mission is to make excellent healthcare a basic human right, ensuring that everyone can quickly access the care they need. By identifying outbreaks at the household level and targeting treatments and vaccines where they are needed most, Akido Labs aims to prevent future pandemics. The company is driven by principles of empathy, equity, and technological innovation, striving to bridge the gap between advanced medical technology and accessible healthcare. With a global team of 1000 dedicated professionals, Akido Labs is at the forefront of reimagining healthcare for a better world.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- West Hollywood, United States
- Employees
- 176
- Open positions
- 11
- Dealroom signal
- 94.9/100
- Industry
- Health, Enterprise Software
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Hospital, Hard Tech, YC W15
- Business model
- SaaS
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Akido Labs.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | May 2025 | $60M | $240M | Jeff Dean · Dentons · Future Communities Capital · GrECo Group | ↗ |
| EARLY VCOther financing | Dec 2020 | $6.2M | $25M | Undisclosed | — |
Growth signals
Latest recorded traffic for Akido Labs is 20K monthly website visits, up 42.9% over the last three months. Akido Labs's team grew 63% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
DCVC
Fresh VC
Slow Ventures
Healthy Ventures
Y Combinator
Series A7 investors entered at this stage
Magic Fund
Oak HC/FT
Jeff Dean
Dentons
Future Communities Capital
GrECo Group
Comprehensive Blood & Cancer Center
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Akido Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Akido Labs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.